Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitrase for Severe Vitreous Hemorrhage
NCT00198497Phase 3Completed
- Sponsor
- Bausch + Lomb
- Start
- Jun 1999
- Primary completion
- Sep 2001
- Modality
- Therapeutic Enzymes
- Countries
- 9
01
Overview
Phase 3, randomised, double-blind trial of hyaluronidase (ovine) in Vitreous hemorrhage (VH) (3 arms), sponsored by Bausch + Lomb. Primary endpoint: Vitreous hemorrhage resolution at 3 months. Started Jun 1999; status: completed.
02
Drugs
hyaluronidase (ovine)
03
Conditions
Vitreous hemorrhage (VH)
Beyond the preview
Go deeper on NCT00198497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00198497.